Makhmudova, Umidakhon
Samadifar, Beasat
Maloku, Aurel
Haxhikadrija, Pellumb
Geiling, Jens-Arndt
Römer, Robert
Lauer, Bernward
Möbius-Winkler, Sven
Otto, Sylvia
Schulze, P. Christian
Weingärtner, Oliver http://orcid.org/0000-0002-0236-206X
Funding for this research was provided by:
Universitätsklinikum Jena
Article History
Received: 19 October 2022
Accepted: 20 December 2022
First Online: 5 January 2023
Declarations
:
: U.M. reports speaker fee and travel support from the German Lipid Association (DGFF), honoraria for advisory board from Sanofi and non-monetary cooperation with Novartis. O.W. received honoraria and travel support from AMGEN, Daiichi-Sankyo, Amarin, Novo Nordisk, Novartis, Hexal GmbH, Sanofi-Aventis, Fresenius, Akcea Therapeutics, TAD Pharma, and the German Cardiac Society (DGK). He received honoraria for advisory boards from AMGEN, Sanofi-Aventis, Novartis, Daiichi-Sankyo, Hexal GmbH, Akcea Therapeutics, the German Cardiac Society (DGK) and Pfizer. P.C.S. received honoraria and travel support from Bayer, Astra Zeneca, Daiichi Sankyo, Novartis, Actelion, Roche, Sanofi Aventis, Pharmacosmos, Medtronic, Thoratec, Boehringer Ingelheim, Heartware, Coronus, Abbott, Edwards Inc., Boston Scientific, St. Jude Medical, Abiomed, and the German Cardiac Society (DGK). He received research support from the National Institute of Health (USA), the German Research Foundation, the Else Kröner Fresenius Foundation, German Heart Foundation, the European Society of Cardiology, Actelion, Medtronic, BMBF, Abiomed, Boehringer Ingelheim and Boston Scientific. He served on advisory boards for the German Research Council, Eurotransplant, Novartis, Bayer, Pharmacosmos, Astra Zeneca, Boehringer Ingelheim Inc., the German Cardiac Society and the European Society of Cardiology. Other authors report no conflict of interest.